Investment Overview
An established allergy and immunology practice presents an attractive acquisition or strategic partnership opportunity for healthcare investors, specialty-practice platforms, and strategic operators seeking to enter or expand within the allergy and immunology sector.
The practice has an established patient base, an experienced clinical and administrative team, and meaningful opportunities for continued growth. With 2,936 active patients and 4,760 office visits over the past 12 months, the practice demonstrates an established foundation of patient engagement and ongoing clinical activity.
Operations are supported by one physician, four nurses, and three administrative support professionals. The owner is willing to assist with recruiting, training, and acclimating a successor physician and to remain involved for an extended transition period, supporting continuity of care and an orderly transfer of clinical responsibilities.
Key Investment Highlights
Practice Profile:
Operating Metrics (Most Recent 12 Months)
Active Patients: 2,936*
Total Office Visits: 4,760
Physician: 1
Nursing Staff: 4
Administrative Support Staff: 3
Total Team: 8, including the physician
* Active patients are defined as patients who have had an office visit within the past 12 months.
Clinical Services
The practice focuses on allergy and immunology care, potentially encompassing allergy evaluation and diagnostic testing, asthma management, allergy immunotherapy, skin allergy care, and food allergy evaluation and treatment.
Physician Transition & Continuity
The owner is willing to support the recruitment, training, and acclimation of a replacement physician and remain involved for an extended transition period. This flexibility may help facilitate the transfer of clinical knowledge, preserve patient relationships, and support operational continuity following a transaction.
The anticipated transition structure, duration, and responsibilities would be determined in consultation with the prospective acquirer.
Potential Growth:
A prospective acquirer may be positioned to build upon the existing patient base and clinical infrastructure through:
Sign our NDA to view more information.